A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session0e7441b81a47d30d597764978d42e50547a261b6): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Gut Microbiota Market Insights, Forecast to 2034

img

Global Gut Microbiota Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gut Microbiota Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Gut Microbiota Market
Global Gut Microbiota market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gut Microbiota industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Gut Microbiota key companies include Enterome, ViThera Pharmaceuticals, Ferring, Synlogic, Vedanta Biosciences, Seres Therapeutics, AOBiome and Axial Biotherapeutics, etc. Enterome, ViThera Pharmaceuticals, Ferring are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Gut Microbiota were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Gut Microbiota market and estimated to attract more attentions from industry insiders and investors.
Gut Microbiota can be divided into Therapeutics, Diagnostics and Others,, etc. Therapeutics is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Gut Microbiota is widely used in various fields, such as Autoimmune Disorder, Gastrointestinal Disorder, Diabetes and Obesity, etc. Autoimmune Disorder provides greatest supports to the Gut Microbiota industry development. In 2022, global % revenue of Gut Microbiota went into Autoimmune Disorder filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Gut Microbiota market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Gut Microbiota market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Enterome
ViThera Pharmaceuticals
Ferring
Synlogic
Vedanta Biosciences
Seres Therapeutics
AOBiome
Axial Biotherapeutics
Segment by Type
Therapeutics
Diagnostics
Others

Segment by Application


Autoimmune Disorder
Gastrointestinal Disorder
Diabetes
Obesity
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gut Microbiota introduction, etc. Gut Microbiota Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Gut Microbiota
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gut Microbiota Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Therapeutics
1.2.3 Diagnostics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gut Microbiota Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Autoimmune Disorder
1.3.3 Gastrointestinal Disorder
1.3.4 Diabetes
1.3.5 Obesity
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gut Microbiota Market Perspective (2018-2033)
2.2 Global Gut Microbiota Growth Trends by Region
2.2.1 Gut Microbiota Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gut Microbiota Historic Market Size by Region (2018-2023)
2.2.3 Gut Microbiota Forecasted Market Size by Region (2024-2033)
2.3 Gut Microbiota Market Dynamics
2.3.1 Gut Microbiota Industry Trends
2.3.2 Gut Microbiota Market Drivers
2.3.3 Gut Microbiota Market Challenges
2.3.4 Gut Microbiota Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gut Microbiota by Players
3.1.1 Global Gut Microbiota Revenue by Players (2018-2023)
3.1.2 Global Gut Microbiota Revenue Market Share by Players (2018-2023)
3.2 Global Gut Microbiota Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gut Microbiota, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gut Microbiota Market Concentration Ratio
3.4.1 Global Gut Microbiota Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gut Microbiota Revenue in 2022
3.5 Global Key Players of Gut Microbiota Head office and Area Served
3.6 Global Key Players of Gut Microbiota, Product and Application
3.7 Global Key Players of Gut Microbiota, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gut Microbiota Breakdown Data by Type
4.1 Global Gut Microbiota Historic Market Size by Type (2018-2023)
4.2 Global Gut Microbiota Forecasted Market Size by Type (2024-2033)
5 Gut Microbiota Breakdown Data by Application
5.1 Global Gut Microbiota Historic Market Size by Application (2018-2023)
5.2 Global Gut Microbiota Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gut Microbiota Market Size (2018-2033)
6.2 North America Gut Microbiota Market Size by Type
6.2.1 North America Gut Microbiota Market Size by Type (2018-2023)
6.2.2 North America Gut Microbiota Market Size by Type (2024-2033)
6.2.3 North America Gut Microbiota Market Share by Type (2018-2033)
6.3 North America Gut Microbiota Market Size by Application
6.3.1 North America Gut Microbiota Market Size by Application (2018-2023)
6.3.2 North America Gut Microbiota Market Size by Application (2024-2033)
6.3.3 North America Gut Microbiota Market Share by Application (2018-2033)
6.4 North America Gut Microbiota Market Size by Country
6.4.1 North America Gut Microbiota Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Gut Microbiota Market Size by Country (2018-2023)
6.4.3 North America Gut Microbiota Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gut Microbiota Market Size (2018-2033)
7.2 Europe Gut Microbiota Market Size by Type
7.2.1 Europe Gut Microbiota Market Size by Type (2018-2023)
7.2.2 Europe Gut Microbiota Market Size by Type (2024-2033)
7.2.3 Europe Gut Microbiota Market Share by Type (2018-2033)
7.3 Europe Gut Microbiota Market Size by Application
7.3.1 Europe Gut Microbiota Market Size by Application (2018-2023)
7.3.2 Europe Gut Microbiota Market Size by Application (2024-2033)
7.3.3 Europe Gut Microbiota Market Share by Application (2018-2033)
7.4 Europe Gut Microbiota Market Size by Country
7.4.1 Europe Gut Microbiota Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Gut Microbiota Market Size by Country (2018-2023)
7.4.3 Europe Gut Microbiota Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gut Microbiota Market Size (2018-2033)
8.2 China Gut Microbiota Market Size by Type
8.2.1 China Gut Microbiota Market Size by Type (2018-2023)
8.2.2 China Gut Microbiota Market Size by Type (2024-2033)
8.2.3 China Gut Microbiota Market Share by Type (2018-2033)
8.3 China Gut Microbiota Market Size by Application
8.3.1 China Gut Microbiota Market Size by Application (2018-2023)
8.3.2 China Gut Microbiota Market Size by Application (2024-2033)
8.3.3 China Gut Microbiota Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Gut Microbiota Market Size (2018-2033)
9.2 Asia Gut Microbiota Market Size by Type
9.2.1 Asia Gut Microbiota Market Size by Type (2018-2023)
9.2.2 Asia Gut Microbiota Market Size by Type (2024-2033)
9.2.3 Asia Gut Microbiota Market Share by Type (2018-2033)
9.3 Asia Gut Microbiota Market Size by Application
9.3.1 Asia Gut Microbiota Market Size by Application (2018-2023)
9.3.2 Asia Gut Microbiota Market Size by Application (2024-2033)
9.3.3 Asia Gut Microbiota Market Share by Application (2018-2033)
9.4 Asia Gut Microbiota Market Size by Region
9.4.1 Asia Gut Microbiota Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Gut Microbiota Market Size by Region (2018-2023)
9.4.3 Asia Gut Microbiota Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gut Microbiota Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Gut Microbiota Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gut Microbiota Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gut Microbiota Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Gut Microbiota Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Gut Microbiota Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gut Microbiota Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gut Microbiota Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Gut Microbiota Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Gut Microbiota Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gut Microbiota Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Gut Microbiota Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gut Microbiota Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Enterome
11.1.1 Enterome Company Details
11.1.2 Enterome Business Overview
11.1.3 Enterome Gut Microbiota Introduction
11.1.4 Enterome Revenue in Gut Microbiota Business (2018-2023)
11.1.5 Enterome Recent Developments
11.2 ViThera Pharmaceuticals
11.2.1 ViThera Pharmaceuticals Company Details
11.2.2 ViThera Pharmaceuticals Business Overview
11.2.3 ViThera Pharmaceuticals Gut Microbiota Introduction
11.2.4 ViThera Pharmaceuticals Revenue in Gut Microbiota Business (2018-2023)
11.2.5 ViThera Pharmaceuticals Recent Developments
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Gut Microbiota Introduction
11.3.4 Ferring Revenue in Gut Microbiota Business (2018-2023)
11.3.5 Ferring Recent Developments
11.4 Synlogic
11.4.1 Synlogic Company Details
11.4.2 Synlogic Business Overview
11.4.3 Synlogic Gut Microbiota Introduction
11.4.4 Synlogic Revenue in Gut Microbiota Business (2018-2023)
11.4.5 Synlogic Recent Developments
11.5 Vedanta Biosciences
11.5.1 Vedanta Biosciences Company Details
11.5.2 Vedanta Biosciences Business Overview
11.5.3 Vedanta Biosciences Gut Microbiota Introduction
11.5.4 Vedanta Biosciences Revenue in Gut Microbiota Business (2018-2023)
11.5.5 Vedanta Biosciences Recent Developments
11.6 Seres Therapeutics
11.6.1 Seres Therapeutics Company Details
11.6.2 Seres Therapeutics Business Overview
11.6.3 Seres Therapeutics Gut Microbiota Introduction
11.6.4 Seres Therapeutics Revenue in Gut Microbiota Business (2018-2023)
11.6.5 Seres Therapeutics Recent Developments
11.7 AOBiome
11.7.1 AOBiome Company Details
11.7.2 AOBiome Business Overview
11.7.3 AOBiome Gut Microbiota Introduction
11.7.4 AOBiome Revenue in Gut Microbiota Business (2018-2023)
11.7.5 AOBiome Recent Developments
11.8 Axial Biotherapeutics
11.8.1 Axial Biotherapeutics Company Details
11.8.2 Axial Biotherapeutics Business Overview
11.8.3 Axial Biotherapeutics Gut Microbiota Introduction
11.8.4 Axial Biotherapeutics Revenue in Gut Microbiota Business (2018-2023)
11.8.5 Axial Biotherapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gut Microbiota Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Therapeutics
Table 3. Key Players of Diagnostics
Table 4. Key Players of Others
Table 5. Global Gut Microbiota Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Gut Microbiota Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gut Microbiota Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gut Microbiota Market Share by Region (2018-2023)
Table 9. Global Gut Microbiota Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gut Microbiota Market Share by Region (2024-2033)
Table 11. Gut Microbiota Market Trends
Table 12. Gut Microbiota Market Drivers
Table 13. Gut Microbiota Market Challenges
Table 14. Gut Microbiota Market Restraints
Table 15. Global Gut Microbiota Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gut Microbiota Revenue Share by Players (2018-2023)
Table 17. Global Top Gut Microbiota by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiota as of 2022)
Table 18. Global Gut Microbiota Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Gut Microbiota Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Gut Microbiota, Headquarters and Area Served
Table 21. Global Key Players of Gut Microbiota, Product and Application
Table 22. Global Key Players of Gut Microbiota, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gut Microbiota Revenue Market Share by Type (2018-2023)
Table 26. Global Gut Microbiota Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gut Microbiota Revenue Market Share by Type (2024-2033)
Table 28. Global Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gut Microbiota Revenue Share by Application (2018-2023)
Table 30. Global Gut Microbiota Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gut Microbiota Revenue Share by Application (2024-2033)
Table 32. North America Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Gut Microbiota Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Gut Microbiota Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Gut Microbiota Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Gut Microbiota Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Gut Microbiota Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Gut Microbiota Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Gut Microbiota Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Gut Microbiota Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Gut Microbiota Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Gut Microbiota Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Gut Microbiota Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Gut Microbiota Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Gut Microbiota Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Gut Microbiota Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Gut Microbiota Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Gut Microbiota Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Gut Microbiota Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gut Microbiota Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gut Microbiota Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gut Microbiota Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gut Microbiota Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gut Microbiota Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Gut Microbiota Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gut Microbiota Market Size by Country (2024-2033) & (US$ Million)
Table 64. Enterome Company Details
Table 65. Enterome Business Overview
Table 66. Enterome Gut Microbiota Product
Table 67. Enterome Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 68. Enterome Recent Developments
Table 69. ViThera Pharmaceuticals Company Details
Table 70. ViThera Pharmaceuticals Business Overview
Table 71. ViThera Pharmaceuticals Gut Microbiota Product
Table 72. ViThera Pharmaceuticals Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 73. ViThera Pharmaceuticals Recent Developments
Table 74. Ferring Company Details
Table 75. Ferring Business Overview
Table 76. Ferring Gut Microbiota Product
Table 77. Ferring Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 78. Ferring Recent Developments
Table 79. Synlogic Company Details
Table 80. Synlogic Business Overview
Table 81. Synlogic Gut Microbiota Product
Table 82. Synlogic Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 83. Synlogic Recent Developments
Table 84. Vedanta Biosciences Company Details
Table 85. Vedanta Biosciences Business Overview
Table 86. Vedanta Biosciences Gut Microbiota Product
Table 87. Vedanta Biosciences Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 88. Vedanta Biosciences Recent Developments
Table 89. Seres Therapeutics Company Details
Table 90. Seres Therapeutics Business Overview
Table 91. Seres Therapeutics Gut Microbiota Product
Table 92. Seres Therapeutics Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 93. Seres Therapeutics Recent Developments
Table 94. AOBiome Company Details
Table 95. AOBiome Business Overview
Table 96. AOBiome Gut Microbiota Product
Table 97. AOBiome Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 98. AOBiome Recent Developments
Table 99. Axial Biotherapeutics Company Details
Table 100. Axial Biotherapeutics Business Overview
Table 101. Axial Biotherapeutics Gut Microbiota Product
Table 102. Axial Biotherapeutics Revenue in Gut Microbiota Business (2018-2023) & (US$ Million)
Table 103. Axial Biotherapeutics Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gut Microbiota Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Gut Microbiota Market Share by Type: 2022 VS 2033
Figure 3. Therapeutics Features
Figure 4. Diagnostics Features
Figure 5. Others Features
Figure 6. Global Gut Microbiota Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Gut Microbiota Market Share by Application: 2022 VS 2033
Figure 8. Autoimmune Disorder Case Studies
Figure 9. Gastrointestinal Disorder Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Obesity Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Gut Microbiota Report Years Considered
Figure 15. Global Gut Microbiota Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Gut Microbiota Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Gut Microbiota Market Share by Region: 2022 VS 2033
Figure 18. Global Gut Microbiota Market Share by Players in 2022
Figure 19. Global Top Gut Microbiota Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiota as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Gut Microbiota Revenue in 2022
Figure 21. North America Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Gut Microbiota Market Share by Type (2018-2033)
Figure 23. North America Gut Microbiota Market Share by Application (2018-2033)
Figure 24. North America Gut Microbiota Market Share by Country (2018-2033)
Figure 25. United States Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Gut Microbiota Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Gut Microbiota Market Share by Type (2018-2033)
Figure 29. Europe Gut Microbiota Market Share by Application (2018-2033)
Figure 30. Europe Gut Microbiota Market Share by Country (2018-2033)
Figure 31. Germany Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Gut Microbiota Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Gut Microbiota Market Share by Type (2018-2033)
Figure 39. China Gut Microbiota Market Share by Application (2018-2033)
Figure 40. Asia Gut Microbiota Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Gut Microbiota Market Share by Type (2018-2033)
Figure 42. Asia Gut Microbiota Market Share by Application (2018-2033)
Figure 43. Asia Gut Microbiota Market Share by Region (2018-2033)
Figure 44. Japan Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Gut Microbiota Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Gut Microbiota Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Gut Microbiota Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Gut Microbiota Market Share by Country (2018-2033)
Figure 54. Brazil Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Gut Microbiota Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Enterome Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 61. ViThera Pharmaceuticals Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 62. Ferring Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 63. Synlogic Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 64. Vedanta Biosciences Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 65. Seres Therapeutics Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 66. AOBiome Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 67. Axial Biotherapeutics Revenue Growth Rate in Gut Microbiota Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries